{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:32:13Z","timestamp":1760783533232},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.remn.2011.12.001","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T19:16:14Z","timestamp":1334862974000},"page":"308-314","source":"Crossref","is-referenced-by-count":1,"title":["18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"A.M.","family":"Garc\u00eda Vicente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Soriano Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Relea Calatayud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mu\u00f1oz Madero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Molina Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Le\u00f3n Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Cordero Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Pilkington Woll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Chac\u00f3n L\u00f3pez-Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Palomar Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2011.12.001_bib0005","first-page":"1819","article-title":"Potential of dual-time-point imaging to improve breast cancer diagnosis with F-FDG PET","volume":"46","author":"Kumar","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2011.12.001_bib0010","first-page":"1440","article-title":"Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes","volume":"47","author":"Mavi","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2011.12.001_bib0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2007.2001","article-title":"NCCN Task Force Report: positron emission tomography (PET)\/computed tomography (CT) scanning in cancer","volume":"5 Suppl. 1","author":"Podoloff","year":"2007","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.remn.2011.12.001_bib0020","series-title":"Breast. AJCC cancer staging manual","first-page":"347","year":"2010"},{"key":"10.1016\/j.remn.2011.12.001_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.remn.2010.02.004","article-title":"Diagnostic and therapeutic impact of 18F-FDG-PET\/CT in patients with suspected breast cancer recurrence","volume":"29","author":"Palomar Mu\u00f1oz","year":"2010","journal-title":"Rev Esp Med Nucl"},{"key":"10.1016\/j.remn.2011.12.001_bib0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00432-003-0536-5","article-title":"Preoperative evaluation of prognosis in breast cancer patients by [(18)F] 2-deoxy-2-fluoro-d-glucose-positron emission tomography","volume":"130","author":"Inoue","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.remn.2011.12.001_bib0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/bjs.6459","article-title":"Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer","volume":"96","author":"Gil-Rendo","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.remn.2011.12.001_bib0040","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00259-007-0459-5","article-title":"[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy","volume":"34","author":"Berriolo-Riedinger","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.12.001_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10549-006-9159-2","article-title":"Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer","volume":"98","author":"Kumar","year":"2006","journal-title":"Breast Cancer Res Treatment"},{"key":"10.1016\/j.remn.2011.12.001_bib0050","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1177\/000313480707301116","article-title":"Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors","volume":"73","author":"Ikenaga","year":"2007","journal-title":"Am Surg"},{"key":"10.1016\/j.remn.2011.12.001_bib0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2325\/jbcs.14.260","article-title":"The relationship between FDG uptake in PET scans and biological behavior in breast cancer","volume":"14","author":"Shimoda","year":"2007","journal-title":"Breast Cancer"},{"key":"10.1016\/j.remn.2011.12.001_bib0060","first-page":"9","article-title":"Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis","volume":"42","author":"Avril","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2011.12.001_bib0065","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00259-002-0880-8","article-title":"FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters","volume":"29","author":"Buck","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.12.001_bib0070","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2967\/jnumed.106.037440","article-title":"The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions","volume":"48","author":"Mavi","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2011.12.001_bib0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2967\/jnumed.108.060459","article-title":"18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis","volume":"51","author":"Osborne","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2011.12.001_bib0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00259-010-1640-9","article-title":"Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer","volume":"38","author":"Groheux","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.12.001_bib0085","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1200\/JCO.2002.02.026","article-title":"Revision of the American joint Committee on cancer staging system for breast cancer","volume":"20","author":"Singletary","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2011.12.001_bib0160","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s10147-010-0120-3","article-title":"Value of PET-FDG in primary breast cancer based on histopathological a immunohistochemical prognostic factors","volume":"15","author":"Heudel","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.remn.2011.12.001_bib0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jjco\/hyn019","article-title":"Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography\/computed tomography fusion imaging (18F-FDG PET\/CT) in primary breast cancer","volume":"38","author":"Ueda","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.remn.2011.12.001_bib0100","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.2000.18.16.2948","article-title":"Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival","volume":"18","author":"Pich","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2011.12.001_bib0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11307-007-0121-4","volume":"10","author":"Basu","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.remn.2011.12.001_bib0110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrc2715","article-title":"p53 and metabolism","volume":"9","author":"Vousden","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.remn.2011.12.001_bib0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","article-title":"TIGAR, a p53-inducible regulator of glycolysis and apoptosis","volume":"126","author":"Bensaad","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.remn.2011.12.001_bib0120","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s002590050319","article-title":"Association between F-18 fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation","volume":"25","author":"Crippa","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.remn.2011.12.001_bib0125","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/cncr.23226","volume":"112","author":"Basu","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.remn.2011.12.001_bib0130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1200\/JCO.2004.07.058","article-title":"18F-2-Fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer","volume":"22","author":"van der Hoeven","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2011.12.001_bib0135","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1002\/cncr.24534","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography (FDG-PET\/CT) imaging in the staging and prognosis of inflammatory breast cancer","volume":"115","author":"Alberini","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.remn.2011.12.001_bib0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.remn.2010.05.002","article-title":"Added value of prone position technique for PET-TAC in breast cancer patients","volume":"29","author":"Vidal-Sicart","year":"2010","journal-title":"Rev Esp Med Nucl"},{"key":"10.1016\/j.remn.2011.12.001_bib0145","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.crad.2008.03.014","article-title":"Dual time point FDG-PET\/CT imaging. Potential tool for diagnosis of breast cancer","volume":"63","author":"Zytoon","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1016\/j.remn.2011.12.001_bib0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00432-003-0536-5","article-title":"Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-deoxy-2-fluoro-d-glucose-positron emission tomography","volume":"130","author":"Inoue","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.remn.2011.12.001_bib0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12282-008-0065-9","article-title":"Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy","volume":"16","author":"Uematsu","year":"2009","journal-title":"Breast Cancer"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X12000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X12000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T11:50:59Z","timestamp":1642074659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X12000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S2253654X12000431"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2011.12.001","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}